Yes, with careful evaluation
Diabetes patients frustrated as popularity of Ozempic and Trulicity limits supply
Ein genauer Zeitpunkt ist unklar, da zunchst die laufenden Phase-3-Studien abgeschlossen und ausgewertet werden mssen
doi: 10.3389/fendo.2024.1372992 Received 19 January 2024 Accepted 20 May 2024 Published 25 June 2024 Volume 15 - 2024 Edited by Devjit Tripathy, The University of Texas Health Science Center at San Antonio, United States Reviewed by Adrian Soto-Mota, National Institute of Medical Sciences and Nutrition Salvador Zubirn, Mexico Anapaula Sommer Vinagre, Federal University of Rio Grande do Sul, Brazil Updates Copyright 2024 Buenaventura-Collazos, Garca-Ramos, Balczar-Valencia, Aguilar-Londoo, Coronel-Restrepo, Monsalve-Arango, Cuesta-Castro and Ramrez-Rincn
All market data is hosted and powered by Barchart
More serious but rare adverse effects include pancreatitis, gallbladder disease, and potential thyroid C-cell tumors (based on rodent studies